During the past decade, Middlemore Clinical Trials conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 4 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Middlemore Clinical Trials" #1 sponsor was "Arrowhead Pharmaceuticals" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Loxo Oncology, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Middlemore Clinical Trials" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "NAMSA" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Middlemore Clinical Trials" are "COVID-19" (2 trials), "Hepatitis B, Chronic" (2 trials), "Primary Myelofibrosis" (2 trials), "Acute Kidney Injury Due to Sepsis" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Middlemore Clinical Trials" in a lesser frequency.

Most popular intervention types in "Middlemore Clinical Trials" are "Drug" (18 trials), "Other" (6 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "ARO-APOC3" (3 trials), "Pirtobrutinib" (2 trials), "Rituximab" (2 trials) and "ARO-HBV Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Middlemore Clinical Trials" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Middlemore Clinical Trials". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 5 completed trials in Middlemore Clinical Trials, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Middlemore Clinical Trials, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".